Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures

Annals of Clinical and Laboratory Science

Volumn 37, Issue 3, 2007, Pages 222-232

  Fisher, Alexander A ^a   Southcott, Emma K ^a   Srikusalanukul, Wichat ^a   Davis, Michael W ^a   Hickman, Peter E ^a   Potter, Julia M ^a   Smith, Paul N ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

Bone turnover markers; Cardiac troponin I; Hip fracture; Mortality; PTH; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; CALCIUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; MAGNESIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; TROPONIN I; VITAMIN D;

AGE; AGED; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; COMORBIDITY; FEMALE; GENDER; HEART MUSCLE INJURY; HIP FRACTURE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 34548182007     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 2005;331:1374.
2. Fisher AA, Davis MW, Rubenach SE, Sivakumaran S, Smith PN, Budge MM. Outcomes for older patients with hip fractures: the impact of orthopedic and geriatric medicine cocare. J Orthop Trauma 2006;20:172-180.
3. Scheini H, Virtanen T, Kentala E, Uotila P, Laitio T, Hartiala J, Heikkila H, Sariola-Heinonen K, Pullisaar O, Yli-Mayry S, Jalonen J. Epidural infusion of bupivacaine and fentanyl reduces perioperative myocardial ischaemia in elderly patients with hip fracture: a randomized controlled trial. Acta Anaesthesiol Scand 2000;44:1061-1070.
4. Nettleman MD, Alsip J, Schrader M, Schulte M. Predictors of mortality after acute hip fracture. J Gen Intern Med 1996;11:765-767.
5. Bhattacharyya T, Iorio R, Healy WL. Rate of and risk factors for acute inpatient mortality after orthopaedic surgery. J Bone Joint Surg Am 2002;84A:562-572.
6. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12:2131-2138.
7. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 2006;70:351-357.
8. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 2005;16:1788-1793.
9. von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999;106:273-278.
10. Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005;20:1912-1920.
11. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006;92:39-48.
12. Laguardia SP, Dockery BK, Bhattacharya SK, Nelson MD, Carbone LD, Weber KT. Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure. Am J Med Sci 2006;332:112-118.
13. Sambrook PN, Chen JS, March LM, Cameron, ID, Cumming RG, Lord SR, Schwarz J, Seibel MJ. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin D status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004;89:5477-5481.
14. Adams JE III, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davila-Roman VG, Bodor GS, Ladenson JH, Jaffe AS. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. NEJM 1994;330:670-674.
15. Apple FS, Ler R, Chung AY, Berger MJ, Murakami MM. Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome. Clin Chem 2006;52:322-325.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470.
17. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia, Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005;182:281-285.
18. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999;281:1505-1511.
19. Sahota O, Gaynor K, Harwood RH, Hosking DJ. Hypovitaminosis D and "functional hypoparathyroidism" - the NoNoF (Nottingham Neck of Femur) study. Age Ageing 2001;30:467-472.
20. Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, Pioli G. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest 2006;29:809-813.
21. Falch JA, Mowe M, Bohmer T, Haug E. Serum levels of intact parathyroid hormone in elderly patients with hip fracture living at home. Acta Endocrinol 1992;126:10-12.
22. Erem C, Tanakol R, Alagol F, Omer B, Cetin O. Relationship of bone turnover parameters, endogenous hormones and vit D deficiency to hip fracture in elderly postmenopausal women. Int J Clin Pract 2002;56:333-337.
23. Martin M, Mullenix P, Rhee P, Belzberg H, Demetriades D, Salim A. Troponin increases in the critically injured patient: mechanical trauma or physiologic stress? J Trauma 2005;59:1086-1091.
24. Ammann P, Pfisterer M, Fehr T, Rickli H. Raised cardiac troponins. BMJ 2004;328:1028-1029.
25. Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 2004;125:1877-1884.
26. Schluter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998;37:34-41.
27. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease: a review. Eur Heart J 2004;25:1776-1787.
28. Horl WH. The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. Nephrol Dial Transplant 2004;19(Suppl 5):V2-8.
29. Varosy PD, Shlipak MG, Vittinghoff E, Black DM, Herrington D, Hulley SB, Browner WS. Fracture and the risk of coronary events in women with heart disease. Am J Med 2003;115:196-202.
30. McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 2004;23:1-10.
31. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501.
32. Ljunghall S, Lundin L, Hvarfner A, Joborn H, Wide L. Serum electrolytes and parathyroid hormone concentrations in acute myocardial infarction. Exp Clin Endocrinol 1986;88:95-100.
33. Herrmann G, Hehrmann R, Scholz HC, Atkinson M, Lichtlen P, von zur Muhlen A, Hesch RD. Parathyroid hormone in coronary artery disease: results of a prospective study. J Endocrinol Invest 1986;9:265-271.
34. Joborn H, Lundin L, Hvarfner A, Johansson G, Wide L, Ljunghall S. Serum electrolytes and parathyroid hormone in patients in a coronary care unit. J Intern Med 1989;225:9-14.
35. Carlstedt F, Lind L, Wide L, Lindahl B, Hanni A, Rastad J, Ljunghall S. Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest 1997;27:977-981.
36. Lind L, Carlstedt F, Rastad J, Stiernstrom H, Stridsberg M, Ljunggren O, Wide L, Larsson A, Hellman P, Ljunghall S. Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med 2000;28:93-99.
37. Smogorzewski M, Tian J, Massry SG. Down-regulation of PTH-PTHrP receptor of heart in CRF: role of [Ca2+]i. Kidney Int 1995;47:1182-1186.
38. Silverberg SJ. Editorial: cardiovascular disease in primary hyperparathyroidism. J Clin Endocrinol Metab 2000;85:3513-3514.
39. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur J Cardiovasc Prev Rehabil 2004;11:69-74.
40. Moniz C, Dew T, Dixon T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin 2005;21:1891-1894.
41. Sakuma M, Endo N, Oinuma T, Hayami T, Endo E, Yazawa T, Watanabe K, Watanabe S. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 2006;17:1608-1614.
42. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-373.
43. Silver J, Levi R. Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin Nephrol 2005;63:119-126.
44. Sahota O, Mundey MK, San P, Godber IM, Hosking DJ. Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006;17:1013-1021.
45. Chen JS, Cameron ID, Cumming RG, Lord SR, March LM, Sambrook PN, Simpson JM, Seibel MJ. Effect of age-related chronic immobility on markers of bone turnover. J Bone Mineral Res 2006;21:324-331.
46. Khosla S, Atkinson EJ, Melton LJ III, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 1997;82:1522-1527.
47. Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK. Optimal vitamin D status and serum parathyroid hormone concentrations in African-American women. Am J Clin Nutr 2006;84:602-609.
48. Nuti R, Martini G, Valenti R, Gambera D, Gennari L, Salvadori S, Avanzati A. Vitamin D status and bone turnover in women with acute hip fracture. Clin Orthop Relat Res 2004:208-213.
49. Seibel MJ. Biochemical markers of bone turnover, part II: clinical applications in the nanagement of osteoporosis. Clin Biochem Rev 2006;27:123-138.
50. Akesson K, Vergnaud P, Delmas PD, Obrant KJ. Serum osteocalcin increases during fracture healing in elderly women with hip fracture. Bone 1995;16:427-430.
51. Mawer EB, Davies M. Vitamin D nutrition and bone disease in adults. Rev Endocr Metab Disord 2001;2:153-164.
52. Ng K, St John A, Bruce DG. Secondary hyperparathyroidism, vitamin D deficiency and hip fracture: importance of sampling times after fracture. Bone Miner 1994;25:103-109.
53. Johansen A, Stone MD, O'Mahony MS, Westlake H, Woodhead JS, Woodhouse KW. Reliability of parathyroid hormone measurements in the period immediately following hip fracture. Age Ageing 1997;26:175-178.